CD44 and breast carcinoma: More specifically, a novel animal model of breast cancer metastasizing to bone has been investigated which consisted of injecting human CD44+/CD24−/low BCSCs subpopulation from MDA-MB-231 cells in mice previously implanted with human bone in the right or left dorsal flanks [253].